325 related articles for article (PubMed ID: 5530511)
21. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
22. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
[TBL] [Abstract][Full Text] [Related]
23. Mass immunization of children in Iran with live attenuated Sugiyama measles virus adapted to calf kidney cell cultures.
Mirchamsy H; Shafyi A; Bahrami S; Nazari P; Mirzadeh M; Bassali Y
Jpn J Exp Med; 1971 Feb; 41(1):39-48. PubMed ID: 5313449
[No Abstract] [Full Text] [Related]
24. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
[No Abstract] [Full Text] [Related]
25. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
Sekiguchi H; Numazaki Y; Ikeda M; Yano N
Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
[No Abstract] [Full Text] [Related]
26. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
[No Abstract] [Full Text] [Related]
27. Live, attenuated mumps-virus vaccine.
Hilleman MR; Buynak EB; Weibel RE; Stokes J
N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
[No Abstract] [Full Text] [Related]
28. [Clinical and serological studies of live attenuated mumps virus vaccine--inoculation of mumps vaccine singly and in combination with measles vaccine].
Kawanishi K
Kansenshogaku Zasshi; 1971 Feb; 45(2):54-66. PubMed ID: 4995912
[No Abstract] [Full Text] [Related]
29. Development and evaluation of the Moraten measles virus vaccine.
Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
[No Abstract] [Full Text] [Related]
30. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
[No Abstract] [Full Text] [Related]
31. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
[No Abstract] [Full Text] [Related]
32. Studies on live attenuated mumps virus vaccine. 1. Attenuation of mumps virus by serial passage in the chorioallantoic cavity of developing chick embryos and field trials by the inhalation method.
Hosai H; Yamanishi K; Ueda S; Minekawa Y; Ogino T
Biken J; 1970 Jun; 13(2):121-6. PubMed ID: 4990327
[No Abstract] [Full Text] [Related]
33. Studies on live attenuated mumps vaccine. I. Comparative field trials with two different live vaccines.
Isomura S; Asano Y; Hon AS; Miyata T; Suzuki S
Biken J; 1973 Jun; 16(2):39-42. PubMed ID: 4729799
[No Abstract] [Full Text] [Related]
34. Simultaneous administration of live virus vaccines. Measles, mumps, poliomyelitis, and smallpox.
Karchmer AW; Friedman JP; Casey HL; Shope TC; Riker JB; Kappelman MM; Witte JJ
Am J Dis Child; 1971 May; 121(5):382-8. PubMed ID: 4933290
[No Abstract] [Full Text] [Related]
35. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
Topciu V; Moldovan E; Csaky N; Băcilă E
Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
[No Abstract] [Full Text] [Related]
36. Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination.
Ueda S; Takahashi M; Kurimura T; Suzuki N; Yamanishi K
Biken J; 1971 Sep; 14(3):247-51. PubMed ID: 4258008
[No Abstract] [Full Text] [Related]
37. [Fever reaction and the effect on antibody formation of vaccination with commercially available KL measles vaccine, with special reference take-rate of live vaccine and need for additional immunization].
Santo K; Tatsumi H; Kato K; Hanaya T; Abe S
Nihon Shonika Gakkai Zasshi; 1969 Apr; 73(4):594-9. PubMed ID: 5817479
[No Abstract] [Full Text] [Related]
38. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
Willis MF; Warburton MF
Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
[No Abstract] [Full Text] [Related]
39. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
[TBL] [Abstract][Full Text] [Related]
40. Wild measles virus strain: isolation and identification.
Tikhonova NT; Mamaeva TA; Naumova MA; Leschinskaja EV; Volkov MV; Martynenko IM
Acta Virol; 1992 Dec; 36(6):557-66. PubMed ID: 1363990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
